Por: Associated Press Tech November 01, 2022
NEW YORK (AP) — The clip-on devices that use light to measure oxygen levels in the blood are getting a closer look from U.S. regulators after recent studies suggest they don’t work as well for patients of color. The devices, called pulse oximeters, usually snap onto a finger and are widely used in hospitals across the globe to help guide treatment. At-home versions became popular during the COVID-19 pandemic.But several recent studies have... + full article
Los Angeles Times USA Science November 02, 2022
The clip-on devices that use light to measure oxygen levels in the blood are getting a closer look from U.S. regulators after recent studies suggest they don't work as well for patients of color. The devices, called pulse oximeters, usually snap onto a finger and are widely... + más
Dangerously wrong oxygen readings in dark-skinned patients spur FDA scrutiny | Ars Technica
FDA advisers meet on racial disparities in pulse oximeters | WPLG Local 10
ABC News USA Health November 01, 2022
NEW YORK -- The clip-on devices that use light to measure oxygen levels in the blood are getting a closer look from U.S. regulators after recent studies suggest they don't work as well for patients of color. The devices, called pulse oximeters, usually snap onto a finger... + más
WPLG Local 10 USA Politics November 01, 2022
NEW YORK – The clip-on devices that use light to measure oxygen levels in the blood are getting a closer look from U.S. regulators after recent studies suggest they don't work as well for patients of color. The devices, called pulse oximeters, usually snap onto a finger... + más
FDA advisers meet on racial disparities in pulse oximeters | ABC News
WPLG Local 10 USA Health October 19, 2022
WASHINGTON – Federal health advisers have concluded that a drug intended to prevent premature births hasn't been shown to work, clearing the way for U.S. regulators to follow through on a long-delayed effort to get it off the market.The Food and Drug Administration’s... + más
FDA panel backs removal of unproven pregnancy drug | 10 WBNS
FDA panel backs removal of unproven pregnancy drug | ABC News
Portland Press Herald USA Health October 19, 2022
WASHINGTON — Federal health advisers have concluded that a drug intended to prevent premature births hasn’t been shown to work, clearing the way for U.S. regulators to follow through on a long-delayed effort to get it off the market. A panel of federal advisers says Makena,... + más
FDA panel backs removal of unproven pregnancy drug | WPLG Local 10
ABC News USA Health September 30, 2022
WASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.Amylyx Pharmaceuticals said the Food and... + más
Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post
ALS drug wins FDA approval despite questionable data | WPLG Local 10
Ars Technica USA Science September 19, 2022
Navigate Filter by topic Settings Front page layout Site theme Comment activity Sign up or login to join the discussions! Sign up to comment and more - Sep 15, 2022 11:04 pm UTC / A nurse uses a pulse oximeter on a patient in Plainfield, New Jersey, on October 26, 2016. Share... + más
How concierge medicine is changing the way people access health care | The Advocate
New test can detect plaques early in the disease: Alzheimer's Q&A | The Advocate
About iurex | Privacy Policy | Disclaimer |